EL7.AI
StocksUpdated•Originally published 6 July 2026•Updated 6 July 2026•
2 min read

Mixed Analyst Adjustments Target Financials and Healthcare as MetLife and Citizens Financial See Upgrades

Key Facts

1Morgan Stanley downgraded Brown & Brown (BRO) to Underweight and lowered its price target to $55.
2Morgan Stanley downgraded Truist Financial (TFC) to Equal-Weight and lowered its price target to $54.

In a move reflecting a broad reassessment of investment positions, top Wall Street analysts issued a series of price target adjustments spanning the insurance, banking, and healthcare sectors. Morgan Stanley raised its target for MetLife (MET) to $103 while maintaining an 'Overweight' rating, while Goldman Sachs boosted targets for Citizens Financial Group (CFG) to $84 and Fifth Third Bancorp (FITB) to $66. Conversely, Evercore ISI took a more cautious stance on medical technology, lowering targets for Becton Dickinson (BDX) and Danaher (DHR).

These adjustments arrive amid diverging sector performances; while the insurance sector benefits from improved investment yields, healthcare faces valuation pressures. Per market data, MetLife is trading at robust levels compared to peers like Prudential Financial, as the 10.7% target price hike reinforces confidence in its cash flow outlook. In banking, Goldman's upgrades for CFG and FITB signal optimism regarding net interest margin recovery, contrasting with earlier caution observed in other regional lenders like Truist Financial.

Regarding market levels, MET stood at $72.45 and CFG closed at $35.12 (close July 2, 2026). Investors are now monitoring the upcoming Consumer Price Index (CPI) release in the economic calendar, as inflation data will play a pivotal role in determining interest rate trajectories, directly impacting the valuations of rate-sensitive banks and insurers in the coming weeks.